FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients.
about
Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.How interacting pathways are regulated by miRNAs in breast cancer subtypes.FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice.A functional variant rs4442975 modulating FOXA1-binding affinity does not influence the risk or progression of breast cancer in Chinese Han population.Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
P2860
FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
FOXA1 Expression Significantly ...... sitive Breast Cancer Patients.
@en
FOXA1 Expression Significantly ...... sitive Breast Cancer Patients.
@nl
type
label
FOXA1 Expression Significantly ...... sitive Breast Cancer Patients.
@en
FOXA1 Expression Significantly ...... sitive Breast Cancer Patients.
@nl
prefLabel
FOXA1 Expression Significantly ...... sitive Breast Cancer Patients.
@en
FOXA1 Expression Significantly ...... sitive Breast Cancer Patients.
@nl
P2093
P2860
P1476
FOXA1 Expression Significantly ...... sitive Breast Cancer Patients.
@en
P2093
Jian Guo Shen
Jufeng Guo
Lin Bo Wang
Zhi Nong Jiang
P2860
P2888
P304
P356
10.1245/S10434-014-4313-2
P50
P577
2015-02-24T00:00:00Z
P5875
P6179
1047149727